

Fundamental dimension Equity attribute | ATLCPLeader $21.45▼-0.28% Cap $1.29BP/E 10.2x QuantScore65/100 | ALLYPeer $39.64▲+2.16% Cap $12.06BP/E 9.0x QuantScore44/100 | BFHPeer $105.66▲+0.89% Cap $4.06BP/E 8.2x QuantScore61/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
16/100 |
61/100 |
95/100 |
Valuation Multiples, PEG & DCF upside | 91/100 | 74/100 | 87/100 |
Health Piotroski, Altman Z, leverage & liquidity | 37/100 | 23/100 | 31/100 |
Growth Revenue / earnings growth & margins | 82/100 | 25/100 | 41/100 |
Sentiment Analyst ratings, targets & revisions | 100/100 | 38/100 | 53/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 10.2x | 9.0x | 8.2x |
Forward P/E (next FY) | 2.2x | 7.9x | 8.1x |
EV / EBITDA (TTM) | 23.0x | 9.7x | 4.3x |
Price / Sales | 0.9x | 0.8x | 0.8x |
Price / Free Cash Flow | 1.6x | -36.9x | 1.9x |
PEG ratio | 0.29 | 0.05 | 0.28 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 8 / 9 | 8 / 9 |
Altman Z-Score | -0.13 (Distress) | -0.62 (Distress) | -0.04 (Distress) |
Total debt / equity | 8.48 | 1.67 | 0.91 |
Quick ratio | 14.9x | 0.2x | 0.3x |
Interest coverage | 0.7x | 0.3x | 0.9x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +53.3% | -25.7% | -2.1% |
Net income growth YoY | +9.8% | +27.5% | +87.0% |
Gross margin (TTM) | 82.9% | 49.8% | 64.0% |
Operating margin (FY) | 22.7% | 8.6% | 13.1% |
FCF margin (FY) | 89.8% | -5.3% | 44.5% |
5. Trailing price performancePrice change over period |
1M return | -10.3% | +4.8% | +5.6% |
3M return | -12.1% | -7.7% | -1.2% |
6M return | -9.7% | -9.5% | +23.7% |
Year to date | -10.7% | -12.5% | +42.7% |
1Y return | -9.9% | -0.8% | +69.8% |
3Y return | +6.9% | +65.9% | +289.3% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $175.87 +719.9% upside | $-98.64 -348.8% premium | $89.47 -15.3% premium |
Wall Street consensus target | — — | $47.50 +19.8% · range $40.00–$56.00 | $116.58 +10.3% · range $104.00–$132.00 |
Consensus stance | 100% Buy0% Hold0% Sell | 63% Buy34% Hold3% Sell | 41% Buy57% Hold3% Sell |